Galera Therapeutics, Inc.

Galera Therapeutics, Inc.verified

GRTX

Price:

$0.0381

Market Cap:

$2.07M

Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical trial for the treatment of radiotherapy induced severe oral mucositis in patients with head and neck cancer (HNC); in Phase IIa clinical trial for the treatment of radiotherapy-induced esophagitis in patients with lung cancer; and in Phase IIa clinical trial for patients with HNC undergoing standard-of-care radiotherapy. It is also involved in developing ...[Read more]

Industry

Biotechnology

IPO Date

2019-11-07

Stock Exchange

NASDAQ

Ticker

GRTX

The Current Ratio as of November 2024 (TTM) for Galera Therapeutics, Inc. (GRTX) is 5.63

According to Galera Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 5.63. This represents a change of 12.49% compared to the average of 5.00 of the last 4 quarters.

Galera Therapeutics, Inc. (GRTX) Historical Current Ratio (quarterly & annually)

How has GRTX Current Ratio performed in the past?

The mean historical Current Ratio of Galera Therapeutics, Inc. over the last ten years is 6.78. The current 5.63 Current Ratio has changed 8.20% with respect to the historical average. Over the past ten years (40 quarters), GRTX's Current Ratio was at its highest in in the December 2018 quarter at 13.01. The Current Ratio was at its lowest in in the March 2018 quarter at 0.

Quarterly (TTM)
Annual

Average

6.78

Median

5.58

Minimum

2.88

Maximum

13.01

Galera Therapeutics, Inc. (GRTX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Galera Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 268.42%

Maximum Annual Current Ratio = 13.01

Minimum Annual Increase = -54.00%

Minimum Annual Current Ratio = 2.88

Quarterly (TTM)
Annual
YearCurrent RatioChange
20234.3651.49%
20222.88-51.86%
20215.987.24%
20205.58-54.00%
201912.13-6.80%
201813.01268.42%

Galera Therapeutics, Inc. (GRTX) Average Current Ratio

How has GRTX Current Ratio performed in the past?

The current Current Ratio of Galera Therapeutics, Inc. (GRTX) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

4.41

5-year avg

6.19

10-year avg

6.78

Galera Therapeutics, Inc. (GRTX) Current Ratio vs. Peers

How is GRTX’s Current Ratio compared to its peers?

Galera Therapeutics, Inc.’s Current Ratio is less than Mereo BioPharma Group plc (6.10), less than Terns Pharmaceuticals, Inc. (32.99), greater than PDS Biotechnology Corporation (0.00), less than Inozyme Pharma, Inc. (7.68), greater than HOOKIPA Pharma Inc. (3.26), greater than X4 Pharmaceuticals, Inc. (4.89), less than Acumen Pharmaceuticals, Inc. (10.43), less than Day One Biopharmaceuticals, Inc. (14.62), greater than Amylyx Pharmaceuticals, Inc. (4.55),

Build a custom stock screener for Galera Therapeutics, Inc. (GRTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Galera Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Galera Therapeutics, Inc. (GRTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Galera Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Galera Therapeutics, Inc.'s Current Ratio?

How is the Current Ratio calculated for Galera Therapeutics, Inc. (GRTX)?

What is the highest Current Ratio for Galera Therapeutics, Inc. (GRTX)?

What is the 3-year average Current Ratio for Galera Therapeutics, Inc. (GRTX)?

What is the 5-year average Current Ratio for Galera Therapeutics, Inc. (GRTX)?

How does the current Current Ratio for Galera Therapeutics, Inc. (GRTX) compare to its historical average?